William Blair & Company’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,696
| Closed | -$6K | – | 1901 |
|
|
2022
Q3 | $6K | Hold |
35,696
| – | – | ﹤0.01% | 1765 |
|
|
2022
Q2 | $21K | Hold |
35,696
| – | – | ﹤0.01% | 1723 |
|
|
2022
Q1 | $47K | Buy |
35,696
+12,810
| +56% | +$16.9K | ﹤0.01% | 1717 |
|
|
2021
Q4 | $60K | Buy |
22,886
+4,886
| +27% | +$12.8K | ﹤0.01% | 1757 |
|
|
2021
Q3 | $56K | Buy |
18,000
+1,000
| +6% | +$3.11K | ﹤0.01% | 1674 |
|
|
2021
Q2 | $63K | Sell |
17,000
-89,500
| -84% | -$332K | ﹤0.01% | 1666 |
|
|
2021
Q1 | $368K | Buy |
106,500
+39,000
| +58% | +$135K | ﹤0.01% | 1256 |
|
|
2020
Q4 | $227K | Buy |
+67,500
| New | +$227K | ﹤0.01% | 1378 |
|